PA1010

· Zhejiang Palo Alto Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PA1010, covering 2023-01-31 to 2023-01-31. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Characteristics of PA1010 in HBV Patients [Phase 1, Phase 2]

See pricing